Incorporating New IO Therapies - Managing Patient Side Effects

from AUAUniversity · host American Urological Association

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of adverse events, the AUA is producing a series of online activities for clinicians and other healthcare professionals. The 2018 series is comprised of a variety of activities, including four live webinars, webcasts and podcasts plus three podcast addressing the barriers to immunotherapy treatment of GU cancer. All activities are complimentary. Breaking Down the Barriers: Incorporating New IO Therapies Podcast Series - Managing Patient Side Effects is the second podcast in a 3-part series. CME Available: https://auau.auanet.org/node/20963

Episode metadata supplied by the publisher feed · Published Oct 19, 2018

Embed this episode

Attribution link and audio player

NOW PLAYING

Incorporating New IO Therapies - Managing Patient Side Effects

0:00 30:37

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of AUAUniversity?

This episode is 30 minutes long.

When was this AUAUniversity episode published?

This episode was published on October 19, 2018.

Can I download this AUAUniversity episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!